Harris Perlman, PhD, professor in Medicine-Rheumatology, will succeed Richard Pope, MD, as chief of Rheumatology.
New Drug Reverses Anticoagulant Effects of Common Blood Thinner
A study showed that an investigational drug, idarucizumab, reverses the anticoagulant effect of dabigatran, a blood thinning drug used for the prevention of stroke. This is the first test of this reversal agent in patients with bleeding or need for emergent surgery.
Is Upward Mobility Bad For Your Health?
Children from low-income families who succeed academically and socially have increased cellular aging, according to a new Northwestern Medicine study.